CA3069167C - Composition pour la guerison des blessures - Google Patents

Composition pour la guerison des blessures Download PDF

Info

Publication number
CA3069167C
CA3069167C CA3069167A CA3069167A CA3069167C CA 3069167 C CA3069167 C CA 3069167C CA 3069167 A CA3069167 A CA 3069167A CA 3069167 A CA3069167 A CA 3069167A CA 3069167 C CA3069167 C CA 3069167C
Authority
CA
Canada
Prior art keywords
wound healing
composition
hydrolyzed collagen
topical composition
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA3069167A
Other languages
English (en)
Other versions
CA3069167A1 (fr
Inventor
George D. Petito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA3069167A priority Critical patent/CA3069167C/fr
Publication of CA3069167A1 publication Critical patent/CA3069167A1/fr
Application granted granted Critical
Publication of CA3069167C publication Critical patent/CA3069167C/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A61K35/64—Insects, e.g. bees, wasps or fleas
    • A61K35/644—Beeswax; Propolis; Royal jelly; Honey
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Insects & Arthropods (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Animal Husbandry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

ABRÉGÉ : La composition pour la guérison des blessures facilite la guérison de tissus endommagés, promeut la croissance de tissus et de cellules, protège les cellules et les tissus, et réduit le tissu cicatriciel. La composition comprend le collagène hydrolysé, le lactosérum et le stéarate de magnésium. La composition pour la guérison des blessures démontre un flux amélioré, une augmentation de facilité de fabrication, ainsi que dapplication sur un site de plaie. Le collagène hydrolysé peut comprendre un collagène hydrolysé de source bovine et un collagène hydrolysé de source marine. La composition peut également comprendre un additif, comme un agent thérapeutique, un antimicrobien, une vitamine ou un conservateur. CA 3069167 2020-01-22
CA3069167A 2020-01-22 2020-01-22 Composition pour la guerison des blessures Active CA3069167C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA3069167A CA3069167C (fr) 2020-01-22 2020-01-22 Composition pour la guerison des blessures

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA3069167A CA3069167C (fr) 2020-01-22 2020-01-22 Composition pour la guerison des blessures

Publications (2)

Publication Number Publication Date
CA3069167A1 CA3069167A1 (fr) 2021-07-22
CA3069167C true CA3069167C (fr) 2024-03-19

Family

ID=76969166

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3069167A Active CA3069167C (fr) 2020-01-22 2020-01-22 Composition pour la guerison des blessures

Country Status (1)

Country Link
CA (1) CA3069167C (fr)

Also Published As

Publication number Publication date
CA3069167A1 (fr) 2021-07-22

Similar Documents

Publication Publication Date Title
CA2409076C (fr) Composition et methode pour cultiver, proteger et reparer des tissus et des cellules
US8168599B2 (en) Composition and method for healing tissues
CA2312558C (fr) Adhesif tissulaire contenant du collagene
US20130245528A1 (en) Compositions Comprising Placental Collagen for Use in Wound Healing
KR101918452B1 (ko) 카복시메틸키토산과 가교된 히알루론산 및 콜라겐을 포함하는 조성물 및, 그 제조방법
US20050208114A1 (en) Composition and method for healing tissues
KR102350526B1 (ko) 응집성이 개선된 창상피복재 조성물의 제조 방법
RU2188206C2 (ru) Способ стерилизации нативного коллагена в жидкой среде, полученный стерильный нативный коллаген, содержащие его композиции и их применение
US20020061842A1 (en) Method for sterilizing a native collagen in liquid medium, sterile native collagen obtained, compositions containing it and uses
PL202536B1 (pl) Zastosowanie preparatu aktywnej substancji szkliwa
RS61100B1 (sr) Mikrosfere koje sadrže antelmintične makrociklične laktone
KR102311547B1 (ko) 지혈 및 상처치유용 창상피복재 및 이의 제조 방법
US9782458B2 (en) Composition for tissue/cell repair
US20200023042A1 (en) Composition for wound healing
US9125892B2 (en) Composition for reduced scar formation of wounds
Subramanya et al. Current trends and controversies in periodontal dressing–A narrative review
US20150216947A1 (en) Method and composition for tissue/cell repair
CA3069167C (fr) Composition pour la guerison des blessures
US20230082131A1 (en) Compositions including amelogenin and uses thereof
CN111012944A (zh) 一种基于藻酸盐和透明质酸的液体敷料及其制备方法
US20250041376A1 (en) Wound healing and tissue repair composition and method
US20240325503A1 (en) Wound healing and tissue repair composition and method using low molecular weight collagen and bioactive glass
US20230310553A1 (en) Wound healing and tissue repair composition and method using low molecular weight collagen and bioactive glass
US20240207351A1 (en) Tissue repair and wound healing composition and method using low molecular weight hydrolyzed collagen
US20250388648A1 (en) Low molecular weight hydrolyzed collagen composition

Legal Events

Date Code Title Description
MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 5TH ANNIV.) - SMALL

Year of fee payment: 5

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250117

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250117

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250117

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 6TH ANNIV.) - SMALL

Year of fee payment: 6

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20260116

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20260116